Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC

Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as treatment for Coronavirus Disease 2019 (COVID-19). We compared the mortality and clinical outcome of patients with COVID-19 who received 200mL of CCP with a Spike protein IgG tit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hyun ah, Bartash, Rachel, Gendlina, Inessa, Rivera, Johanna, Nakouzi, Antonio, Bortz, Robert H., Wirchnianski, Ariel S., Paroder, Monika, Fehn, Karen, Serrano-Rahman, Leana, Babb, Rachelle, Sarwar, Uzma N., Haslwanter, Denise, Laudermilch, Ethan, Florez, Catalina, Dieterle, M. Eugenia, Jangra, Rohit K., Fels, J. Maximilian, Tong, Karen, Mariano, Margarette C., Vergnolle, Olivia, Georgiev, George I., Herrera, Natalia G., Malonis, Ryan J., Quiroz, Jose A., Morano, Nicholas C., Krause, Gregory J., Sweeney, Joseph M., Cowman, Kelsie, Allen, Stephanie, Annam, Jayabhargav, Applebaum, Ariella, Barboto, Daniel, Khokhar, Ahmed, Lally, Brianna J., Lee, Audrey, Lee, Max, Malaviya, Avinash, Sample, Reise, Yang, Xiuyi A., Li, Yang, Ruiz, Rafael, Thota, Raja, Barnhill, Jason, Goldstein, Doctor Y., Uehlinger, Joan, Garforth, Scott J., Almo, Steven C., Lai, Jonathan R., Gil, Morayma Reyes, Fox, Amy S., Chandran, Kartik, Wang, Tao, Daily, Johanna P., Pirofski, Liise-anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724683/
https://www.ncbi.nlm.nih.gov/pubmed/33300012
http://dx.doi.org/10.1101/2020.12.02.20242909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724683/
https://www.ncbi.nlm.nih.gov/pubmed/33300012
http://dx.doi.org/10.1101/2020.12.02.20242909

Ejemplares similares